Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
about
Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunitiesWomen and Chest Pain: Recognizing the Different Faces of Angina in the Emergency DepartmentNanoparticle-Based and Bioengineered Probes and Sensors to Detect Physiological and Pathological Biomarkers in Neural CellsFriends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative DiseasesHerpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's DiseaseCells, biomarkers, and post-traumatic stress disorder: evidence for peripheral involvement in a central diseaseFetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventionsBlood-brain barrier breakdown in acute and chronic cerebrovascular diseaseInflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical diseaseFunction of microglia and macrophages in secondary damage after spinal cord injuryHypertension: a harbinger of stroke and dementiaRosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory ConditionMultifaceted role of matrix metalloproteinases (MMPs)Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injuryTwo-dimensional zymography differentiates gelatinase isoforms in stimulated microglial cells and in brain tissues of acute brain injuriesInhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte CulturesGDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body DementiaNeurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersInhibition of MMP-2 but not MMP-9 influences inner ear spiral ganglion neurons in vitro.Contributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction.The Concise Guide to PHARMACOLOGY 2013/14: enzymes.Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small vessel diseaseEffects of progesterone vs. dexamethasone on brain oedema and inflammatory responses following experimental brain resection.Hypoxia-induced neuroinflammatory white-matter injury reduced by minocycline in SHR/SP.Cardiovascular risk factors and small vessel disease of the brain: Blood pressure, white matter lesions, and functional decline in older personsMatrix Metalloproteinase-Mediated Neuroinflammation in Vascular Cognitive Impairment of the Binswanger TypeEarly role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients.Mmp-9, a potential target for cerebral ischemic treatment.Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.MMP-9 inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss after traumatic brain injury in rat.Multifaceted Roles of Metzincins in CNS Physiology and Pathology: From Synaptic Plasticity and Cognition to Neurodegenerative DisordersAlterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease.Solulin reduces infarct volume and regulates gene-expression in transient middle cerebral artery occlusion in ratsMatrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cellsMatrix metalloproteinase-12 deficiency ameliorates the clinical course and demyelination in Theiler's murine encephalomyelitis.Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement.The science of stroke: mechanisms in search of treatments.Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme Activity
P2860
Q26745510-C6F61F7C-194E-4213-BAA5-1736C1351B21Q26746172-418EC276-4A1A-4EBC-AB03-190B860A44CCQ26770769-A65CA2F2-EBBA-47E2-A171-6FEB9C269409Q26779933-ADAE07CD-39A8-41CB-930A-0C3E25E9F3A0Q26781578-6F98A6D4-C97E-45A7-80C1-6BE95125813DQ26830476-B63BB522-239A-419E-AD73-EC34365B06D8Q26996467-8562D71D-57A8-4BE3-91F8-DEFACECD494EQ27010013-EB2FF469-EF92-4198-BB6B-BA33DD886226Q27023953-62256F6C-DFD3-4C2A-9A93-46E6F7B4B5FFQ27024453-95FFFEC3-8DE0-4FBB-B909-EE7F641A604EQ27027494-8B3DEB11-5CA0-4806-896E-C12AED921B58Q28067747-7BCD7657-3FF1-4725-8F00-FD58B7354880Q28083906-1022D9FA-B3DB-4692-B421-3B66F1698328Q28534597-47F80A85-77CB-4923-9496-E56894C02320Q28546063-5D43135E-B28E-4D6B-B9A3-03D02173758EQ28547985-5F232F80-61D2-408A-A136-E774793E3F9DQ28550541-49230F72-B8EB-494C-A73D-AEA2757E38DFQ29615839-B772A76B-1B2A-46C8-996B-459E5F3A7417Q30414848-9CA4BC1B-3098-4595-A279-AC859559EAE1Q30483239-6030B0AA-AEA0-46E2-B94A-3CDD6F749B57Q30486745-D49EBC03-E895-4C9C-BA4E-23270C71B0BFQ30612033-CC4A515B-4E75-4C2A-BC9E-F1C34099E765Q30840745-66C2110E-5817-4975-BC74-AC50FDFA4413Q30899226-3440477F-3F42-4FC2-97C1-33C66DF13B94Q30964050-1AA7E9F7-B2B5-409D-9256-DC3286979849Q31060741-40F51C8D-C556-44AE-90B0-05F56CD00E64Q31109560-688D8145-AF0B-4A86-B1FE-7712D68FC900Q33572001-6456CABC-7424-4DEB-9A6D-24F700EEC47AQ33612510-052434D8-123E-4BB0-9F87-18BB72856AF3Q33728244-3B9F3C3F-F5CE-4211-AC93-36DCF71D7491Q33782706-529ED1D5-4607-4DE5-9A41-091DF0DACC03Q33847555-165129FE-1E51-4C60-B07A-7176456F97BBQ33854483-4A2141F5-3513-4E16-965D-FA4968ACC50CQ34058311-DBDDE61A-934C-4116-9102-DF9CDAA36559Q34074200-5774F11A-D10B-4DD4-BAF9-3437848BB644Q34094501-51339277-1C37-4965-B408-74F615FE6853Q34136881-A4E55B5F-22F4-439E-B954-7AEC5DF8E9F0Q34170971-2E9EEE04-C19D-4E8C-851C-136F3AD0C147Q34212337-9FC485B7-9151-42CB-B7CC-FAB3621D9C60Q34360507-680C1E5D-BEA7-4AB9-BC35-5CEE2E8EBB2E
P2860
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
@en
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
@nl
type
label
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
@en
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
@nl
prefLabel
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
@en
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
@nl
P1433
P1476
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
@en
P2093
Gary A Rosenberg
P304
P356
10.1016/S1474-4422(09)70016-X
P577
2009-02-01T00:00:00Z